-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 6/14 cls Addex Therapeutics Ltd. (SIX:ADXN) Wedbush Christopher Marai Downgrade Neutral (from outperform) 18% CHF3.98 Marai also …
Published on 6/17/2013
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 6/7 cls Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL) Leerink Joseph Schwartz Upgrade Outperform (from market perform) 7% $15.97 …
Published on 6/10/2013
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/31 cls Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) Canaccord Salveen Richter Price target Buy 21% $72.83 JPMorgan Cory Kasimov …
Published on 6/3/2013
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/24 cls Cubist Pharmaceuticals Inc. (NASDAQ:CBST) Jefferies Eun Yang Price target Buy 12% $55.49 RBC Capital Markets Adnan Butt …
Published on 5/27/2013
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/17 cls Actelion Ltd. (SIX:ATLN) UBS Guillaume van Renterghem Downgrade Neutral (from buy) -2% CHF58.80 Renterghem said Actelion's …
Published on 5/20/2013
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/10 cls Corcept Therapeutics Inc. (NASDAQ:CORT) Piper Jaffray Charles Duncan Downgrade Neutral (from overweight) -1% $1.75 Duncan …
Published on 5/13/2013
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/3 cls Amgen Inc. (NASDAQ:AMGN) Jefferies Eun Yang Other Buy -2% $106.48 Yang maintained her buy rating after issuing a note with …
Published on 5/6/2013
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 4/26 cls Amgen Inc. (NASDAQ:AMGN) Piper Jaffray Ian Somaiya Downgrade Neutral (from overweight) -3% $108.38 Somaiya downgraded based …
Published on 4/29/2013
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 4/12 cls Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) Ladenburg Thalmann Juan Sanchez Price target Buy 63% $12.54 MLV George Zavoico …
Published on 4/15/2013
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 4/5 cls Alexza Pharmaceuticals Inc. (NASDAQ:ALXA) Piper Jaffray Charles Duncan Upgrade Overweight (from neutral) 3% $4.56 Duncan also…
Published on 4/8/2013
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 3/28 cls Aastrom Biosciences Inc. (NASDAQ:ASTM) Roth Capital Partners Joseph Pantginis Downgrade Sell (from neutral) -40% $0.70 …
Published on 4/1/2013
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 3/22 cls Aastrom Biosciences Inc. (NASDAQ:ASTM) MLV Megan McCloskey Dow Downgrade Hold (from buy) -10% $1.16 McCloskey Dow also …
Published on 3/25/2013
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 3/15 cls BioDelivery Sciences International Inc. (NASDAQ:BDSI) Piper Jaffray Charles Duncan Upgrade Overweight from neutral) -2% $3.96…
Published on 3/18/2013
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 3/8 cls Dendreon Corp. (NASDAQ:DNDN) ISI Group Mark Schoenebaum Downgrade Hold (from buy) 3% $5.91 Schoenebaum downgraded after …
Published on 3/11/2013
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 3/1 cls Affymax Inc. (NASDAQ:AFFY) MLV Ed Arce Downgrade Hold (from buy) -84% $2.68 Stifel Nicolaus Joel Sendek Downgrade Hold (…
Published on 3/4/2013
-
Analyst picks and changes Company Bank Analyst Coverage Opinion Wk chg 2/22 cls Chelsea Therapeutics Ladenburg Thalmann Juan Sanchez Upgrade Buy (from neutral) 114% $1.69 International Ltd. (NASDAQ:CHTP…
Published on 2/25/2013
-
Analyst picks and change Company Bank Analyst Coverage Opinion Wk chg 2/15 cls Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) MLV Megan McCloskey Dow Downgrade Hold (from buy) -3% $24.09 McCloskey Dow …
Published on 2/18/2013
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 2/8 cls Biogen Idec Inc. (NASDAQ:BIIB) BMO Capital Markets Jim Birchenough Price target Market perform 5% $164.44 Canaccord Ritu …
Published on 2/11/2013
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 2/1 cls Celsion Corp. (NASDAQ:CLSN) Roth Capital Partners Joseph Pantginis Downgrade Neutral (from buy) -83% $1.32 Pantginis also …
Published on 2/4/2013
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/25 cls Becton Dickinson and Co. (NYSE:BDX) Mizuho Peter Lawson Downgrade Neutral (from buy) 1% $84.59 Lawson maintained his $87 …
Published on 1/28/2013
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/18 cls AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) Leerink Joseph Schwartz Upgrade Outperform (from market perform) -3% $15.47 Schwartz…
Published on 1/21/2013
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/11 cls Celgene Corp. (NASDAQ:CELG) Barclays Capital Ying Huang Price target Overweight 17% $96.30 BMO Capital Markets Jim …
Published on 1/14/2013
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/4 cls Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) Jefferies Eun Yang Price target Buy 6% $26.44 Leerink Joseph Schwartz Price …
Published on 1/7/2013
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 12/21 cls Amicus Therapeutics Inc. (NASDAQ:FOLD) Wedbush Gregory Wade Downgrade Underperform (from neutral) $2.76 -53% Wade also …
Published on 12/24/2012
-
Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 12/14 cls Alexza Pharmaceuticals Inc. (NASDAQ:ALXA) Roth Capital Partners Scott Henry New Buy 13% $5.84 Henry set a $10 target ahead …
Published on 12/17/2012